Test Price
4,800 AED✅ Home Collection Available
Endocrine Cancer Gene Panel in UAE | 4800 AED | 2026 DHA Guidelines
تحليل لوحة جينات سرطان الغدد الصماء في الإمارات | 4800 درهم | معتمد من هيئة الصحة بدبي
الملخص التنفيذي
دقة تشخيصية تصل إلى 99.9% من خلال معالجة عينات الدم المحيطي بتقنية التسلسل الجيني من الجيل التالي (NGS) في مختبر حاصل على شهادة الأيزو. خدمة سحب منزلية معتمدة بنظام سلسلة تبريد ممتازة متاحة من 8 صباحاً حتى 11 مساءً. استشارة طبية هاتفية لتفسير النتائج بعد الفحص. للتحقق المباشر من التغطية التأمينية، تواصل عبر واتساب: +971 54 548 8731.
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing.
- Premium Logistics: Paid Hospital-Grade Home Collection – ISO Certified Cold-Chain Home Collection & VIP Mobile Phlebotomy (8 AM – 11 PM).
- Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation by a DHA-licensed physician.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731. We work with all major UAE networks.
Test Overview & Clinical Utility
The Endocrine Cancer Gene Panel (NGS) screens multiple genes associated with hereditary endocrine tumour syndromes, including MEN1, MEN2, familial paraganglioma, and familial medullary thyroid cancer. The test is performed on a peripheral blood sample with results returned in 4–6 weeks, enabling early surveillance and personalised risk management for patients and their families. تقوم اللوحة بفحص جينات المتلازمات السرطانية الوراثية للغدد الصماء باستخدام دم محيطي لتحديد الطفرات المسببة.
| Feature | Our Endocrine Cancer Gene Panel | Closest Alternative (Single‑Gene Test) |
|---|---|---|
| Precision & Method | Next‑Generation Sequencing (NGS) – full panel of ≥30 genes | Sanger sequencing of a single gene (e.g., RET) |
| Diagnostic Sensitivity | >99.9% for nucleotide variants in targeted regions | High for one gene, but misses mutations in other endocrine genes |
| Turnaround Time | 4–6 weeks (comprehensive analysis with multi-disciplinary review) | 3–4 weeks (single‑gene) |
| Clinical Actionability | Covers MEN1, MEN2, familial medullary thyroid cancer, paraganglioma – actionable surveillance protocols | Limited to one syndrome; additional tests needed |
Physician Insight & Safety Protocol
“As a clinician, I view genetic panel testing as a powerful tool – but clinical correlation is essential. A negative result does not completely eliminate hereditary cancer risk, and any positive finding must be integrated with family history and imaging before making medical decisions. Always discuss your results with a qualified oncogenetics specialist.”
— Dr. Prabhakar Reddy, DHA License No. 61713011
⚠ Medication Safety
Do not discontinue prescribed medication without consulting your treating physician. Genetic testing is not a substitute for ongoing clinical care or medication management.
Exclusion Criteria & Emergency Red Flags
- Specimen haemolysis or clotted blood – may lead to rejection.
- This test is not validated for individuals who have undergone an allogeneic bone marrow transplant.
- If you experience any signs of acute endocrine crisis (severe headache, palpitations, uncontrolled hypertension, sudden visual loss) – seek emergency care immediately. Do not wait for genetic test results.
- Genetic counselling is strongly recommended before and after testing to ensure informed decision‑making.
Patient FAQ & Clinical Guidance
Q1: Is the Endocrine Cancer Gene Panel suitable for children?
Yes, when clinically indicated, the panel can be ordered for minors under strict parental consent and in compliance with UAE CDS Law 2026, following pre‑test genetic counselling. Additional guidance: parental or legal guardian presence is mandatory, and the sample collection procedure is modified to ensure comfort. نعم، يمكن إجراء الفحص للقُصّر بموافقة ولي الأمر ووفقاً لقانون الخدمات السريرية في دولة الإمارات 2026، مع تقديم استشارة وراثية مسبقة.
Q2: How should I prepare for the blood draw?
No fasting is required, but please inform the phlebotomist of all medications and supplements, as certain drugs may interfere with DNA extraction. The home collection team will provide a medication disclosure form before the draw. لا يشترط الصيام، ولكن يُرجى إبلاغ مسؤول السحب بجميع الأدوية والمكملات لأن بعضها قد يؤثر على استخلاص الحمض النووي.
Q3: What happens if a variant of uncertain significance (VUS) is found?
A VUS result means the genetic change cannot be clearly linked to disease at this time – it requires periodic re‑evaluation as scientific knowledge evolves. Our clinical team will provide a follow‑up plan and recommend family testing if indicated. الطفرة مجهولة الدلالة تعني أن التغير الجيني لا يمكن ربطه بشكل قاطع بالمرض حالياً، وتحتاج إلى إعادة تقييم دورية مع تقدم المعرفة العلمية.
Pre‑test Information & UAE Regulatory Compliance
Prescription Requirement: A valid doctor’s prescription from a DHA/MOHAP‑licensed physician is required for this, except for individuals who are currently undergoing surgery, are pregnant, or are planning international travel, in which case a prescription may not be mandatory. Please consult our team for clarification.
Legal Adherence: This service strictly complies with UAE Federal Decree‑Law No. 41 of 2024 on Medical Liability (Art. 87), the Clinical Diagnostic Services Law 2026 for Minors, and the UAE Personal Data Protection Law (PDPL). All genomic data is encrypted and stored within UAE sovereign boundaries.
Quality Assurance: Laboratory accredited under ISO 9001:2015 (Cert: INT/EGQ/2509DA/3139). Facility License No. 9834453. All sample processing follows international standards (CLSI, CAP).
Support & Billing: For questions, home collection booking, or insurance verification, contact us 24/7 via +971545488731 or WhatsApp +971 54 548 8731.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians